SEC Form 4 · accession 0002138163-26-000005
Ovid Therapeutics Inc. · OVID
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anna Greka
Director
Period of report
Jun 15, 2026
Accepted (ET)
Jun 17, 2026 · 4:22 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001636651
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.26 | Jun 15, 2026 | A | 130,000 | A | — | Jun 14, 2036 | Common Stock | 130,000 | 130,000 | D |
Explanation of responses
- F1The shares subject to the stock option will vest in 36 equal monthly installments commencing on July 15, 2026, subject to the Reporting Person's continued services through each such date.